December 23, 2008 — In the treatment of advanced ovarian cancer, neoadjuvant chemotherapy before surgical debulking may be the new standard of care — especially in countries where the scheduling of a ...
Significant disparities exist in the adoption of minimally invasive interval debulking surgery for advanced ovarian cancer, with gaps potentially widening as the procedure becomes more common.
CHICAGO -- Upfront surgery for advanced ovarian cancer failed to improve overall survival (OS) versus interval debulking but did improve progression-free survival (PFS) for the first time in a phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback